<DOC>
	<DOCNO>NCT00079833</DOCNO>
	<brief_summary>This research study determine esomeprazole , administer twice daily 40 , 80 , 120 mg dos , control excessive stomach acid secretion .</brief_summary>
	<brief_title>Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion Zollinger-Ellison Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Zollinger-Ellison Syndrome</mesh_term>
	<mesh_term>Gastrinoma</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Males female least 18 year age . Diagnosis ZollingerEllison Syndrome idiopathic hypersecretion Pregnant lactating female History drug addiction alcohol abuse within 12 month prior Screening . History intolerance proton pump inhibitor ingredient formulation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>gastric acid hypersecretory condition</keyword>
	<keyword>Idiopathic Hypersecretion</keyword>
	<keyword>Excessive Gastric Acid secretion</keyword>
</DOC>